Novavax News

Aktie
WKN:  A2PKMZ ISIN:  US6700024010 US-Symbol:  NVAX Branche:  Biotechnologie Land:  USA
6,97 €
-0,23 €
-3,19%
23.04.26
Depot/Watchlist
Marktkapitalisierung *
942,83 Mio. €
Streubesitz
29,59%
KGV
3,13
Nachhaltigkeits-Score
25 %
Index-Zuordnung
-

Novavax News

06.08.25 - PR Newswire
Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights
Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights PR Newswire
30.07.25 - PR Newswire
Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025
Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025 PR Newswire
24.07.25 - PR Newswire
Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study
Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study PR Newswire
11.06.25 - PR Newswire
Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial
Novavax's COVID-19-Influenza Combination and Stand-​alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a ...
29.05.25 - PR Newswire
Novavax to Participate in Upcoming Investor Conferences
Novavax to Participate in Upcoming Investor Conferences PR Newswire
19.05.25 wallstreetONLINE Redaktion
+15 Prozent am Montag: Novavax zündet den Kursturbo: Ist DAS die Chance auf eine Trendwende?
Die Aktie von Novavax geht am Montag durch die Decke und legt deutlich zweistellig zu. Grund hierfür sind gute Nachrichten vom zurückliegenden Wochenende.Auf dem Höhepunkt ...
19.05.25 - PR Newswire
U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine
U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine PR Newswire
08.05.25 - PR Newswire
Novavax Reports First Quarter 2025 Financial Results and Operational Highlights
Novavax Reports First Quarter 2025 Financial Results and Operational Highlights PR Newswire
07.05.25 - PR Newswire
Novavax to Participate in BofA Securities 2025 Health Care Conference
Novavax to Participate in BofA Securities 2025 Health Care Conference PR Newswire
05.05.25 - PR Newswire
Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan
Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan PR Newswire
01.05.25 - PR Newswire
Novavax to Report First Quarter 2025 Financial Results on May 8, 2025
Novavax to Report First Quarter 2025 Financial Results on May 8, 2025 PR Newswire
29.04.25 - PR Newswire
Novavax Appoints Charles Newton to Board of Directors
Novavax Appoints Charles Newton to Board of Directors PR Newswire

Newssuche

Videos

newspaper
20.04.26 0,00%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »